to Committee on Committees (S)
Email me when SB 211 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 211. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill forces Kentucky health insurance plans to place biosimilar drugs on their formularies when the biosimilar’s wholesale acquisition cost is lower than the brand reference product and to offer the same or better cost‑sharing, while banning extra prior‑auth or step‑therapy requirements. It also amends statutes governing limited health‑service benefit plans, post‑secondary institution liability insurance, and the state employee health‑insurance program, adding provisions such as special enrollment for pregnant women and a ban on using state funds for abortion coverage. The act would have applied to plans issued on or after Jan. 1, 2027 but did not pass.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 211
3 free questions a day, no accountHistory
- to Committee on Committees (S)
- introduced in Senate
Sponsors
- C. Richardson
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 211 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 211 freeOr ask your AI assistant about SB 211 directly:
Add to Claude, ChatGPT or Cursor